Abstract
The molecular recognition theory suggests that binding sites of interacting proteins, for example, peptide hormone and its receptor binding site, were originally encoded by and evolved from complementary strands of genomic DNA. To test this theory, we screened a rat kidney complementary DNA library twice: first with the angiotensin II (All) followed by the vasopressin (AVP) antisense oligonucleotide probe, expecting to isolate cDNA clones of the respective receptors. Surprisingly, the identical cDNA clone was isolated twice independently. Structural analysis revealed a single receptor polypeptide with seven predicted transmembrane regions, distinct All and AVP putative binding domains, a Gs, protein–activation motif, and an internalization recognition sequence. Functional analysis revealed specific binding to both All and AVP as well as All– and AVP–induced coupling to the adenylate cyclase second messenger system. Site–directed mutagenesis of the predicted All binding domain obliterates All binding but preserves AVP binding. This corroborates the dual nature of the receptor and provides direct molecular genetic evidence for the molecular recognition theory.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blalock, J.E. & Smith, E.M. Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem. biophys. Res. Commun. 121, 203–207 (1984).
Bost, K.L., Smith, E.M. & Blalock, J.E. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc. riatn. Acad. Sci. USA. 82, 1372–1375 (1985).
Mulcahey, J.J., Neill, J.D., Dion, L.D., Bost, K.L. & Blalock, J.E. Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): Generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc. natn. Acad. Sci. U.S.A. 83, 9714–9718 (1986).
Baranyi, L. et al. The antisense homology box: A new motif within proteins that encodes biologically active peptides. Nature Med. 1, 894–901 (1995).
Carr, D.J., Bost, K.L. & Blalock, J.E. An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor. J. Neuroimmun. 12, 329–337 (1986).
Gorcs, J.J., Gottschall, P.E., Coy, D.H. & Arimura, A. Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide. Peptides 7, 1137–1145(1986).
Knutson, V.P. Insulin-binding peptide: Design and characterization. J. biol. Chem. 263, 14146–14151 (1988).
Abood, L.G., Michael, G.J., Xin, L. & Knigge, K.M. Interaction of putative vaso-pressin receptor proteins of rat brain and bovine pituitary gland with an antibody against a nanopeptide encoded by the reverse message of the complementary mRNA to vasopressin. J. Recept. Res. 9, 19–25 (1989).
Swords, B.H., Carr, D.J.J., Blalock, J.E. & Berecek, K.H. An antibody directed against a peptide encoded by RNA complementary to mRNA for vasopressin recognizes putative vasopressin receptors. Neuroendocrinology 51, 487–492 (1990).
Elton, T.S., Dion, L.D., Bost, K.L., Oparil, S. & Blalock, J.E. Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc. natn. Acad. Sci. U.S.A. 85, 2518–2522 (1988).
Moore, G.J., Ganter, R.C. & Franklin, K.J. Angiotensin “antipeptides”: (−) messenger RNA complementary to human angiotensin II (+) messenger RNA encodes an angiotensin receptor antagonist. Biochem. biophys. Res. Commun. 160, 1387–1391 (1989).
Budisavljevic, M. et al. Antagonist effect of a receptor mimicking peptide encoded by human angiotensin II complementary RNA. Hypertension 19, 345–354 (1992).
Kang, C.Y., Brunck, T.K., Emmons, T.K., Blalock, J.E. & Kohler, H. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science 240, 1034–1036 (1988).
Brentani, R.R. et al. Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approach. Proc. natn. Acad. Sci. U.S.A. 85, 364–367 (1988).
Pasqualini, R., Chamone, D.F. & Brentani, R.R. Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approach. J. biol. Chem. 264, 14566–14570 (1989).
Calvete, J.J. et al. Further studies on the topography of the N-terminal region of human platelet glycoprotein Ilia: Localization of monoclonal antibody epitopes and the putative flbrinogen-binding sites. Biochem. J. 274, 457–463 (1991).
Ghiso, J., Saball, E., Leoni, J., Rostagno, A. & Frangione, B. Binding of cystatin C to C4: The importance of sense-antisense peptides in their interaction. Proc. natn. Acad. Sci. U.S.A. 87, 1288–1291 (1990).
de Souza, S.J. & Brentani, R. Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions. J. biol. Chem. 267, 13763–13767 (1992).
Castronova, V., Taraboletti, B. & Sobel, M. Laminin receptor complementary DNA deduced synthetic peptide inhibits cancer cell attachment to endothelium. Cancer Res. 51, 5672–5678 (1991).
Morel, F., Imbert-Teboul, M. & Chabardes, D. Receptors to vasopressin and other hormones in the mammalian kidney. Kidney Int. 31, 512–520 (1987).
Kyte, J. & Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. molec. Biol. 157, 105–132 (1982).
Engleman, D.M., Steitz, T.A. & Goldman, A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. biophys. Chem. 15, 321–353 (1986).
Okamoto, T. et al. Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 67, 723–730 (1991).
Blackshear, P.J., Nairn, A.C. & Kuo, J.F. Protein kinases 1988: A current perspective. FASEB J. 2, 2957–2969 (1988).
Davis, C.G. et al. Mutation in familial hypercholesterolemia: Amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell 45, 15–24 (1986).
Davis, C.G., Van Driel, I.R., Russell, D.W., Brown, M.S. & Goldstein, J.L. The low density lipoprotein receptor: Identification of amino adds in cytoplasmic domain required for rapid internalization. J. biol. Chem. 262, 4075–4082 (1987).
Chen, W.J., Goldstein, J.L. & Brown, M.S. NPSY, a sequence often found in cytoplasmic tails is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. biol. Chem. 265, 3116–3123 (1990).
Taylor, M.E., Conary, J.T., Lennartz, M.R., Sthal, P.D. & Drickramer, K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate recognition domains. J. biol. Chem. 265, 12156–12162 (1990).
Trowbridge, I.S. Endocytosis and signals for internalization. Curr. Opin. Cell Biol. 3, 634–641 (1991).
Murphy, T.J., Alexander, R.W., Griendling, K.K., Runge, M.S. & Bernstein, K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351, 233–236 (1991).
Sasaki, K. et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351, 230–233 (1991).
Sandberg, K., Ji, H., Clark, A.J.L., Shapira, H. & Cart, K.J. Cloning and expression of a novel angiotensin II receptor subtype. J. biol. Chem. 267, 9455–9458 (1992).
Lolait, S.J. et al. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357, 336–339 (1992).
Birnbaumer, M. et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature 357, 333–335 (1992).
Morel, A., O'Carroll, A.M., Brownstein, M.J. & Lolait, S.J. Molecular cloning and expression of a rat V1aarginine vasopressin receptor. Nature 356, 532–526 (1992).
Sugimoto, T. et al. Molecular cloning and functional expression of a cDNA encoding the human Vlb vasopressin receptor. J. biol. Chem. 269, 27088–27092 (1994).
Jard, S. Vasopressin isoreceptors in mammals: Relation to cyclic AMP-dependent and cyclic AMP-independent transduction mechanisms. Curr. Topics Membranes Transp. 18, 255–285 (1983).
Jard, S. Vasopressin antagonists. Adv. Nephrol. 16, 1–16 (1987).
Pals, D.T., Masucci, F.D., Denning, G.S., Sipos, F. & Fessler, D.C. Role of the pressor action of angiotensin II in experimental hypertension. Circulation Res. 29, 673–681 (1971).
Khosla, M.C. et al. Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone. J. med. Chem. 15, 792–795 (1972).
Munoz-Ramirez, H., Khosla, M.C., Hall, M.M., Bumpus, F.M. & Khairallah, P.A. In vitro and in vivo studies of [1-sarcosine, 8-threonine]angiotensin II. Res. Commun. Chem. Pathol. Pharmacol. 13, 649–663 (1976).
Manning, M. et al. Potent and selective antagonists of the antidiuretic responses to arginine vasopressin based on modifications of [1-(β-mercapto-(β,β-pentamethylenepropionic acid), 2-D-isoleucine, 4-valine] arginine-vasopressin at position 4. J. med. Chem. 27, 423–429 (1984).
Dohlman, H.G., Caron, M.G. & Lefkowitz R.J. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 26, 2657–2664 (1987).
Douglas, J.G. Angiotensin receptor subtypes of the kidney cortex. Am. J. Physiol. 253, F1–F7 (1987).
Ohkubo, H. et al. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc. natn. Acad. Sci. U.S.A. 80, 2196–2200 (1983).
Ivell, R. & Richter, D. Structure and comparison of the oxytocin and vasopressin genes from rat. Proc. natn. Acad. Sci. U.S.A. 81, 2006–2010 (1984).
Rogers, T.B., Gaa, S.T. & Alien, I.S. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J. Pharmac. exp. Ther. 236, 438–444 (1986).
Herrera, V.L.M., Chobanian, A.V. & Ruiz-Opazo, N. Isoform-specific modulation of Na+,K+-ATPase α-subunit gene expression in hypertension. Science 241, 221–223 (1988).
Phillipson, O.T. & Gonzalez, C.B. Distribution of axons showing neurophysin-like immunoreactivity in cortical and anterior basal forebrain sites. Brain Res. 258, 33–44 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruiz-Opazo, N., Akimoto, K. & Herrera, V. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nat Med 1, 1074–1081 (1995). https://doi.org/10.1038/nm1095-1074
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1095-1074
This article is cited by
-
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla
Kidney International (2009)
-
Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3
Nature Medicine (2004)
-
The Dual AngII/AVP Receptor Gene N119S/C163R Variant Exhibits Sodium-Induced Dysfunction and Cosegregates With Salt-Sensitive Hypertension in the Dahl Salt-Sensitive Hypertensive Rat Model
Molecular Medicine (2002)
-
Identification of a Novel V1-type AVP Receptor Based on the Molecular Recognition Theory
Molecular Medicine (2001)
-
Molecular Characterization of a Dual Endothelin-1/Angiotensin II Receptor
Molecular Medicine (1998)